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Recent research has stressed the toxigenic potentiality of the various strains 
of Staphylococcus aureus, demonstrating the manifold effects of Staphylococcua 
aureus in producing dermonecrosis, hemolysis, and death (1). 
It is the general opinion among those who have surveyed the peculiar trends 
of bacteria that chromogenesis and other characteristic activities of these one- 
celled organisms will function only when environment is most favorable.  This 
has  been demonstrated  with Staphylococcus  aureus  in  the conversion of the 
virulent normal S yellow colony to the avirulent white R configuration by pro- 
viding unfavorable conditions for growth with the simple addition of certain 
dyes and salts to the media (2).  This modification was temporary, and passage 
in vi~o inevitably terminated with the reversion of the variant form to the orig- 
inal type of colonial growth (2, 3). 
Recently, work in these laboratories has shown that when brain (4) or spleen 
(5) extract is incorporated in the media, the yellow S is converted to the white 
R  form and  is so maintained  in  repeated subcultures on this  same  media. 
Moreover, conversion in vivo has been produced by injection of brain extract 
into animals infected with the yellow S organism  (4).  It was these findings 
which led us to conduct the present more extensive investigations of brain and 
spleen extracts, as well as of heart and kidney extract.  The studies included 
(a) determination of the pathogenicity of the variant of Staphylococcus aureus; 
(b) the prevention and treatment of staphylococcic infections with the various 
extracts, using different methods of inducing infection and of administering the 
extracts; (c) a study of the mechanism of the action of the extracts both on toxin 
production by the organism, and on the toxin; and  (d)  determination of the 
acute and chronic toxicities of the extracts. 
EXPERIMENTAL 
Comparison of Pathogenicity of S  and R  Forms of Staphylococcus aureus.  In 
vitro Studies.--Extraction  and alcohol-precipitation of heart and kidney tissues 
from beef were made according to our original procedure (6) for spleen and brain 
except that distilled water was substituted for Drew's solution.  All extracts, 
prior to further use, were checked for conversion activity in vitro on a virulent 
strain of Staphylococcus aureus cultured from an infected tonsil.  The results 
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with all of the extracts were typical of those in previous experiments (5).  In a 
series of three experiments the various tissue extracts were added in concentra- 
tions of 0.5 and 1.0 per cent to the solid nutrient media.  As compared with the 
control plates, there was a depression in the growth rate of the inoculant, and a 
regression in the size of its original area.  In the experimental plates this was 
followed  at the end of 3 days by markedly increased growth, emanating from the 
original area of inoculation, of a white variant which within 2 days was approxi- 
mately 3.5  to 5  times greater in area than that in the control plates.  The 
effects were most marked with brain extract. 
A  series of tests (7-11)  designed to distinguish between pathogenic and non- 
pathogenic strains of Staphylococcus aureus, were conducted in triplicate on both 
the S and R  forms.  From the data in Table I  it would appear that the white 
R variant is non-pathogenic.  Tests for chromogenesis made at intervals during 
2~ years show that the variant has never reverted to the original orange growth. 
TABLE I 
Tests for Distinguishing between V~rulent and A~irulen~ Forms of Staphylococcus aureus 
Test~  Control~yellow organism  ExperhnentalT-gmy'whlte 
organt~n 
Fermentation of mannitol  ................ 
Liquefaction of gelatin  .... 
Chromogenesis  ......................... 
Hemolysis  ............................. 
Coagulase .............................. 
+ 
+ 
-t- yellow 
+ 
+ 
+  very slight 
--  gray white 
Although none of the applied "in vitro" tests serves as a standard whereby a line 
of demarcation between virulence and avirulence can be drawn, some investiga- 
tors maintain that negative reaction to a combination of these tests is a fairly 
accurate indication of non-pathogenicity (1,3, 7-14). 
In vivo Stmties.--To determine whether the avirulence of the white R variant 
could be maintained in vivo, mice, 3 to 5 months old, BBC strain, and albino, 
were used as test animals.  From the 3 to 5 day old experimental plates, yellow 
organisms were obtained from the center of the inoculation area and white or- 
ganisms from the stimulated outgrowth from this area.  Each test animal was 
immediately injected subcutaneously with 1 ml. of saline containing 1 loopful 
of the organisms.  The experiments were made in triplicate using 10 animals 
for the yellow and 10 for the white organisms in each experiment.  Three days 
after injection of the yellow organism, the control animals developed a gradually 
ascending paralysis, with 70 per cent mortality by the 4th day.  The remaining 
30 per cent developed large abdominal abscesses and sloughs which persisted for 
3 weeks.  There was no mortality among the experimental animals receiving 
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per cent had small non-suppurative hemorrhagic abdominal lesions which dis- 
appeared by the 7th day.  Cultures from the lesions in the survivors in each of 
the two groups of animals revealed organisms corresponding in type to those 
injected, evidence for the maintenance of the relative avirulence in vivo of the 
white R variant of the strain of Staphylococcus aureus used in these experiments. 
Treatment of Staphylococcic Infections with Tissue Extracts 
2~rocedure.  Control AnimaIs.--In  the  following experiments  extending  over  a  period 
of 18 months, BBC and albino mice of the Rockland strain 3 to 6 months of age were used. 
The strain of Staphylococcus aureus employed was one obtained from the drainage of an 
infection on the hand and the  organisms were maintained in nutrient broth as  culture 
medium.  At the time of use for infecting mice, saline suspensions were prepared with t 
loopful of a 48 hour culture of the organism per cc. of saline.  The LDso was 0.35 cc.  Lesions 
developed within 1 to 3 days following subcutaneous injection into the ventral abdominal 
region and in the surviving animals required 9 to 30 days to heal.  Abscess  formation was 
followed by extensive sloughing and the appearance  of signs of intoxication,  listlessness, 
inability to eat, shaggy hair, cyanosis, paralysis of the limbs, and death within 5 to 6 days. 
Blood cultures  made from animals dying then showed that death was due to the staphy- 
lococcus.  Following intraperitoneal (0.25 and 0.S cc.) or intravenous (0.1 cc.) injection  of the 
organisms there were no localized lesions, but a generalized reaction occurred characterized 
by roughened fur, listlessness, sluggishness, and reduced activity.  Death occurred in these 
animals within 24 hours and in some instances within a few minutes following  the injection. 
The survivors required 14 and 1S days for recovery. 
Experimental  Animals: Brain Extract.--Brain  extract was  given  subcutaneously  in the 
ventral abdominal region each day to mice for (1) prophylactic  experiments 2 to 6 hours 
prior to infection with Staphylococcus aureus and (2) for therapeutic  experiments on the 1st 
day that lesions developed following  injection, usually after 1 to 3 days, or, in the case of in- 
travenous  and intraperitoneal  infection,  following the  onset  of  the  generalized  reaction. 
Treatment was given daily in 50 rag. doses until the lesions healed completely, as judged by 
scabs dropping off leaving smooth new skin beneath, or until the animals appeared  normal 
following a generalized reaction.  In the therapeutic  experiments the animals were divided 
into control and experimental groups only  after the lesions or the generalized reaction occurred, 
in order to have animals with infections of similar degree of severity in each group.  The oral 
effectiveness of brain extract was tested both therapeutically and prophylactically  using S00 
rag. per 24 hours administered at intervals of 6 hours, through a curved hypodermic needle 
with a blunt edge. 
In another series of experiments the relative effectiveness of decreasing amounts of the 
brain extract was tested against staphylococcic infections grading from a 50 rag. dose of the 
brain extract down to 5 rag. daily in both a prophylactic and therapeutic series of experiments. 
qThe control animals were injected each day with a volume of saline equivalent to that of 
the brain extract. 
Results.--In  25 experiments (Table II) using 50 mg. of brain extract daily in 
the prophylactic treatment of subcutaneous staphylococcic infections (227 con- 
trol and 223 experimental mice) all of the 25 per cent of the controls surviving 
the infection developed typical abscesses which required from 9 to 30 days to 
heal.  The incidence of lesions in the 99 per cent surviving experimental ani- 
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TABLE  H 
E ffed  of Brain  Extract Administered  Subcutaneously  as  Prophylaxis  against  Subcutaneous 
Staphylococcus  aureus Infections in Mic~ 
Experiment No. 
5314 BP 
6194 BP 
7134 BP 
No.  mice  Mor- 
tality Average  Fre- 
day ap- 
peared  quency ' 
per csnt  ~sr cent 
10C  60  3  100 
10E  0  8  60 
9C  44  6  I00 
9E  0  9  55 
10C  70  5  100 
10E  0  5  20 
Leslons--survivors 
Healing time 
Average (range) 
doy, 
12 (2 unhealed 14th day) 
4 (3-6) 
17-25 
7 (6-8) 
10 
3 
3265 BP 
•  545 BP 
.  1105 BP 
355 BP 
3125 BP 
545 BP 
6255 BP 
625 BP 
1105 BP 
2195 BP 
5255 BP 
10C  100  --  -- 
10E  0  4  50 
10C  80  3  100 
10E  0  2  20 
6C  33  2  100 
5E  0  2  33 
6C  33  3  100 
6E  0  4  50 
6C  100  ~ 
6E  0  3  100 
IOC  70  3  i00 
6E  0  3  100 
6C  83  2  100 
6E  0  2  67 
6C  83  2  100 
6E  0  2  67 
6C  33  2  I00 
6E  0  2  67 
10C  60  3  100 
10E  0  4  50 
10C  70  3  I00 
10E  0  3  60 
9  (4-11) 
22 
6 (5-7) 
16 (15-2o) 
8 (7-9) 
28 (27-30) 
s  (5-11) 
7 (6-11) 
21 (18--23) 
8  (5-10) 
20 
9 (7-13) 
23 
5 (3-6) 
18 
7 (5-9) 
17 (10-25) 
6 (4-9) 
17 (12-21) 
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TABLE II--Concluded 
Lesions---survivors 
Experiment No.  No. mice  Mor- 
tality  Average  Fre-  Healing time  day ap-  peared  quency  Averagt (range) 
per c#n~  ~cf ceM  days 
1025 BP  10C  100  --  --  -- 
10E  0  2  50  8 (6-10) 
9115 BP  10C  70  2  100  15 (9-20) 
10E  0  2  60  5 (3-8) 
10115  BP  10C  90  2  I00  22 
10E  0  2  50  5 (4-8) 
10245 BP  6C  100  --  -- 
6E*  0  2  83  5 (4-6) 
11145 BP  10C  100  ~ 
10E  0  2  80  6 (4-8) 
11145 BP  10C  90  2  100  25 
10E  0  3  50  6 (3--10) 
11305 BP  10C  90  3  100  Unhealed on 20th day 
10E  0  3  90  7 (3-11) 
12105 BP  10C  80  2  100  20 (1 unhealed on 21st day) 
10E  0  2  60  7 (4-10) 
12105  BP  6C  67  2  I00  9 (I unhealed  on lIth  day) 
6E  0  2  60  8 (6-10) 
5255 BP  10C  40  3  100  19 (16-22) 
10E  0  3  70  12 (8--14) 
6255 BP  20C  95  3  100  17 
20E  20  7  100  6 (3-8) 
Totals and ....  227C  75 .C  3  100  18 (9--30) 
averages ....  223E  0.9  3  63  7 (3-14) 
Prophylactic dose of 50 mg. brain extract subcutaneously given 2  to  6  hours prior to 
inoculating  with  virulent  Staphylococc~  aurcus,  1.5  LDs0  subcutaneously.  Treatment 
continued at 50 rag. level daily until lesions completely healed, as gauged by the loosening 
of the scab beneath which was a shining new intact skin surface. 
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appearance of the abscesses was not significantly altered in the experimental 
animals.  The abscesses, however, were atypical in appearance,  consisting  of 
small dry lesions which did not progress to the sloughing stage and which healed 
completely in time intervals ranging from 3 to 14 days.  There was no paralysis 
or manifestation of toxic symptoms in the treated animals. 
In 11 therapeutic experiments using a total of 116 control and 116 experimen- 
tal animals (Table III), in which treatment was begun with 50 rag. of brain 
extract daily after the typical lesion following subcutaneous injection of Stapk- 
ylococcus aureus  had developed,  87 per cent of the control animals and 3 per 
cent of the experimental  animals died.  The range of healing time for the sur- 
viving control animals was 14 to 26 days with typical toxic manifestations and 
for the experimental animals, 4 to 15 days, in the absence of symptoms of tox- 
icity. 
The results of treating intraperitoneal infections in 50 mice by subcutaneous 
injection of 50 rag. of brain extract per day, both prophylactically  and therapeu- 
tically, are shown in Table IV.  In the prophylactic series, two-thirds of the 30 
control animals died and the survivors required  14 to 19 days to recover from 
the generalized reaction.  Of the 30 experimental animals that received a single 
preliminary dose of 50 rag. of brain extract subcutaneously, followed by 50 rag. 
per day, one died (1185 BP; the other 9 animals in this group did not react to 
the injection of the organisms in any apparent way) and the remaining experi- 
mental animals seemed normal again within 3 to 8 days.  In the therapeutic 
series, none of the 20 control animals survived the intraperitoneal injection of 
organisms; none of the experimental animals died and  they appeared  to be 
completely recovered within 3 to 5 days. 
None of 35 experimental animals died that received Stapkylococcus  aureus 
intravenously (Table V) and brain extract subcutaneously whether prophylac- 
ticaUy or therapeutically.  The single survivor of the 35 control animals re- 
quired  15  days for  recovery from the  generalized  reaction.  Three, 4, and 
6  days were  required for  recovery  of  the  experimental  animals  with  the 
exception of one group prophylactically  treated (10205 BP) in which there was 
an immediate generalized  reaction of all of the animals to the intravenous 
injection, but within 15  to 30 minutes all had apparently recovered.  Treat- 
ment was continued for 3 days in this group.  All of the control animals died 
within 24 hours of inoculation. 
In Table VI are given the results of using doses of brain extracts graded to as 
low as 5 mg. per day prophylactically in a series of 6 groups of 6 experimental 
animals each, and 1 group of 6 control animals.  There was no mortality among 
the experimental animals until the amount of brain extract was reduced to 10 
and 5 nag. per day, while the healing time was gradually lengthened with the 
daffy administration of smaller amounts.  The single surviving control animal 
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TABLE III 
Tkerapeutic~Res~onse of Mice uqth Subcutaneous Stapkflocoo:us  aureus Inf~tion to Subcutaneous 
Treatment ugth Brain Extract 
Experiment No. 
10194 BT 
625 BT 
No. mice 
10C 
10E 
10C 
Mortality 
pSg CSN[ 
100" 
0 
100 
Survivors 
Healing time 
Average (range) 
da~s 
8  (7-13) 
1295 BT 
755 BT 
9115 BT 
10E 
6C 
6E 
10C 
10E 
10C 
10E 
0 
83 
0 
50 
0 
8O 
0 
8 (6-9) 
23 
9 (7-12) 
16 00-20) 
6 (4-9) 
18 (14-22) 
8 (4-12) 
9295 BT 
10115 BT 
11145 BT 
11165 BT 
525 BT 
6255 BT 
10C 
10E 
10C 
10E 
10C 
10E 
I0C 
10E 
10C 
10E 
20C 
20E 
100 
0 
100 
0 
100 
10 
70 
0 
80 
0 
95 
15 
7 (5-10) 
s (4-11} 
7 (4-9) 
18 (15-21) 
9 (6-13) 
25 (23-26) 
10 (4-15) 
14 
9 (6-13) 
Totals and.  116C  87  19 (14-26) 
averages ........  I  116E  3  8 (4-15) 
Subcutaneous dose of Staphylococcus  aureus  equivalent to  approximately  1.5 LD~. 
Treatment begun only when all animals had open lesions, usually on 2nd or 3rd day after 
injection with  1.5 LD60 of Staphylococcus  aureus and continued until complete healing oc- 
curred, using 50 rag. of brain extract subcutaneously once daily. 
* Mortality 80 per cent at 21 days, 100 per cent at end of 6 weeks, due to secondary out- 
breaks of infection. 
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the same series, there were no deaths in the 6 groups of 10 experimental animMs 
each, while all of~the 10 control animals died.  The healing time with this, as 
with the prophylactic series, was gradually lengthened as the daily amount of 
brain extract injected was reduced. 
TABLE IV 
Response of Mi~e to Subcutaneous Injections of Brain Extract as Prophylactic and Therapeutic 
Treatment of Intra ,eritoneal Infections  witk Stapkylo¢occns aureus 
Survivors--illness 
Experiment No.  No. Mice  Mortality 
Day of  ]  Frequency [  Recovery  time 
onset  Average (range) 
1185 BP 
2185 BP 
11244 BP* 
Totals and ...... 
averages ...... 
Prophylaxis 
peg c#nt 
10C  100 
10E  10 
10C  40 
10E  • 
10C  80 
10E  0 
30C  67 
30E  3 
I  Peg-hi  [  day~  [ 
No illness manifested 
100  14 
100  3 
100  23 
100  8~ 
100  19 
IO0  6 
drays 
(14) 
(3) 
(23) 
(8) 
09) 
(6) 
Therapeusis 
11154 BT§ 
11154 BT~ 
Totals and 
averages.. 
10C 
10E 
10C 
10E 
20C 
20E 
100 
0 
100 
0 
100 
0 
1 
1 
1 
IO0  3 
100  $ 
100  4 
m 
(3) 
(s) 
(4) 
*  All surviving control  animals developed abscesses  at site  of injection; 3 experimental 
animals had slight  sloughs  at site  of  injection  which healed  within 11 days. 
§  0.25  cc.  inoculant  used.  Experimental animals treated  for 10 days. 
H  0.5 cc. inoculant  used. 
Dry slough  appeared at site  of  injection  on day 9 in 3 animals;  healed 11 days later. 
The oral effectiveness  of brain extract therapy for subcutaneous S~zphy- 
Iocor~  aur~ infections  is  demonstrated by the data in  Table VII.  None of 
the treated animals in either  the prophylactic or the therapeutic series  died. 
All  of the controls  for  the therapeutic  series  died.  The two surviving  controls 
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In the 10 experimental animals receiving a single prophylactic dose of 100 mg. 
of brain extract per os only one developed an abscess, which appeared 5 days 
after subcutaneous infection with Staphylococcus aureus; lesions developed in all 
of the control animals of this series on the 2nd day after infection. 
Other Tissue  Extracts.--Therapeutic  tests on subcutaneous  infections with 
the  other  beef  tissue  extracts--liver,  spleen,  heart,  and  kidneynwere  ac- 
companied by results less striking than those with brain extract (Table vln; 
TABLE V 
R~o~e  of Mice to Subcutaneous Injections of Brain Extract as Prophylactic and Therapeutic 
Treatment of Intravenous Infection wltk Staphylococcus aureus 
Experiment No.  No. mice  Mortally  Survivont--illnen  Recovery  time 
Day of onset  [  Frequency  Averq¢ (ra~e) 
Prophylaxis 
195 BP 
10205 BP 
10C 
IOE 
9C* 
9E~ 
per ¢e~l 
lOO 
o 
100 
0 
da~t# 
1  100  3  (2-3) 
Immediate  reaction  of  all  animah  with 
improvement in 15-30 minutes. 
Therapeusis 
195 BT 
213 BT 
10C 
IOE 
6C 
6E 
100 
0  Immediate 
83  1 
0  1 
m 
lOO 
100 
100 
6  (4-8) 
is Os) 
4 (3-4) 
Animals inoculated with 0.1 cc. of a 24 hour culture of organism. 
* All dead ~thin 24 hours of inoculations. 
:~ Treatment continued for 3 days. 
Fig. 1).  There was no mortality when the spleen and the heart extracts were 
used, but a slightly longer time (7 to 12 and 5 to 16 days, respectively) was re- 
quired for complete healing of the lesions than was the case with brain extract 
(3 to 15 days).  The infection in animals treated with kidney extract, however, 
showed but slight improvement as compared with that of the controls and it 
was felt that the poor results in this case may have been due in some measure to 
the toxicity of the extract at the dosage used, since all animals treated with the 
kidney extract exhibited toxic manifestations immediately following injections 
of  the  material.  The  liver  extract  proved  too  toxic  to  warrant  further 
investigation. TABLE  VI 
Effect of Various Subcutaneous Doses of Brain Extract on Subcutaneous Strapkyloco~cus aureus 
Infections in Mice 
Dosage, mg./day ............................  ]50*]40130  20  10  t  5  ]Controls 
Proph ,lactic 
No. mice ......................... 
Mortality, per cent .................. 
Survivors 
Average day for lesions ........... 
Frequency, survivors, per cent  ...... 
Healing time, average, days ........ 
Range, days ..................... 
6 
0 
2 
67 
5 
(3-6) 
6 
0 
2 
67 
5 
(4-8) 
6  6 
0  0 
6 
16 
2 
(5-15) 
6 
33 
2 
(8-13) 
6 
83 
2 
i00 
23 
Therapeutic 
No. mice ..........................  10  10  10  ]  10  10  10  I0 
SurvivorsM°rtality'  per cent  ..................  07  07  1  O1  90  1  O1  1  O1  100 
I 
Healing time, average, days ......... 
Range, days .....................  (5-10)  (4-10)  (3-17)  (5-13)  (8-13)  (7-13) 
* Data included in both Tables LI and III. 
Abscesses in 100 per cent control and experimental animals on 4th day following sub- 
cutaneous inoculation of Staphylococcus aureu,  s.  Brain extract therapy was begun daily on 
day 4 and continued until complete healing occurred as defined in Table II.  Dose of inoculant 
1.5  LD~0. 
TABLE  VII 
Response of Mice with Subcutaneous Staphylococcus aureus Infections to 300 rag. per day of 
Brain Extract Administered Orally 
Experiment No.  No. mice  Mortality 
Leslons--survlvors 
Average day  Frequency  [  Healing  time 
appeared  Average (range) 
Prophylaxis 
per vent  per ¢enL  days 
219.5 BP  10C  80  2  100  18  (15-21) 
10E  0  5  10  5  (5) 
Therapeusis 
3265 BT  10C  100  .... 
10E  0  1  100  8  (4-11) 
Totals  and...  20C  90  2  100  18  (15-21) 
averages ....  20E  0  3  55  7  (4-11) 
Brain extract administered at intervals of 4 hours through a curved needle directly into the 
stomach, a  total of 300 rag. per day being given.  Staphylococcus aureus dose was 1.5 LD~. 
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TABLE VHI 
Response  of Mice to Prophylactic  and Therapeutic  Subcutaneous  Administration of Liver, Heart, 
Kidney, and Spleen Extracts for Control of Staphylococcus  aureus  Infections in Mice 
Liver  I  Heart  [  Kidney  [ 
.Exper°  imental  Control  ~Ee~ntr"  q  I C°nt l  C°ntr°l I 
Spleen 
I Exper-  Control  imental 
Prophylaxis 
No. mice.  6  6  10  10  10  10  6  6 
Mortality, per cent .....  67  83  50  60  60  10  33  0 
Survivors-lesions 
Average day of appear- 
ance.  2  2  1  2  1  2  2  2 
Frequency, per cent.  100  100  100  100  100  55  100  67 
Healing time, average...  16  22  15  13  15  9  18  8 
Range.  (16)  (22)  (14-15)  (12-16) (14-17)  (8-9)  (18)  (7-8) 
No. mice. 
Mortality.. 
Survivors-lesions 
Average day of appear- 
ance. 
Frequency, per cent. 
Healing time, average... 
Range. 
Totals  No. mice ....... 
and aver-  Mortality.. 
ages for  Healing time.. 
prophy-  Range 
lactic ex- 
periments 
6  6  6  6  6  6 
33  0  33  17  83  0 
2  2  2  2  2  2 
100  83  100  83  100  100 
18  8  18  11  23  i0 
(18)  (5-13)  (18)  (7-15)  (23)  (10) 
6  6  16  16  16  16  12  12 
33  83  45  40  50  13  44  0 
4  --  18  I0  17  10  21  9 
(4)  (18)  (5-11)  (14-18)  (8-15)  (18-23)  (7-10) 
Therapeusis 
No. mice ................. 
Mortality ................ 
Survivors-lesions 
Average day of appear- 
ance-. ............... 
Frequency, per cent ..... 
Healing time, average... 
Range ................. 
6 
83 
2 
(23) 
6  6 
83  83 
2  3 
(2s)  (23) 
3 
100 
10 
(7-14) 
6  6 
83  83  . 
I  1 
100  ll~  1 
23 
(23)  (11) I 
6  6 
83  0 
1  1 
120~3  100 
11 
(23)  111-12) 
Subcutaneous infections induced with  1.5  LD~0 Staphylococcus  aureus. 
Mechanism of Action of Tissue Extracts on Staphylococcus aureus in Vivo 
The following investigations are concerned with the effects of the tissue ex- 
tracts on toxin production by Staphylococcus aureus and on the action of the 
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Eztrads  and  Toxl, P~od~tio,.--Control  tubes  containing  nutrient  broth  and  exper- 
imental tubes containing nutrient broth plus 1.0 per cent brain extract were inoculated with 
~qtaphyloco¢¢~ aur~  and allowed to incubate for 48 hours.  Both sets of tubes were then 
centrifuged slowly for 15 minutes at the end of which time the supernatant  materials were 
subjected to several filtrations through Berkefeld filters. 
To determine whether brain extract prevented the formation of toxin by Stapkylocv¢c~ 
aur~  (15),  the experimental and control filtrates were injected into test mice.  The control 
filtrate was divided into 2 parts and 1.0 per cent brain extract was added to one portion to 
eliminate any variable which might have been introduced by the presence of brain extract 
in the experimental filtrate.  In two series of experiments 3 groups of 10 mice each were in- 
jected subcutaneously in the abdominal region with 0.5  ml. of each of the filtrates.  Ob- 
servations on necrosis, hemolysis, and death are recorded in Table IX.  The control filtrate 
was markedly toxic both as to its power to necrose tissue and to produce hemolysis, while that 
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FIO.  I.  Comparison  of therapeutic action of brain, spleen, heart, and  kidney extracts on 
ataphylococcic infections initiated subcutaneously. 
prepared from organisms grown under the influence of the brain extract was non-toxic.  It 
is apparent from the data presented that the hemolytic and necrotizing effects of toxin, while 
not eliminated, were considerably reduced by the simple addition of brain extract to the con- 
trol filtrate. 
To check for the lethal action of the toxin of Staphylococcus aureus, 3 groups of I0 mice 
each  were inoculated intravenously  with the  three  filtrates, each mouse  receiving 0.5 ml. 
There was almost immediate total mortality in the  animals  receiving  the  control  filtrate 
and those  receiving the control filtrate  to which  brain extract had been  added,  but there 
were no ill effects in those animals injected with the filtrate from organisms grown in the 
presence of brain extract. 
The cholesterol content of the extract was 0.032  rag. per dose and the phos- 
pholipid content was too small to determine.  The content of these substances 
is too small to account for the action of the extract against  the strain of Staphy- 
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extracts against the infection is not due to a non-specific effect such as leukocy- 
tosis.  Apparently, therefore, the effectiveness of brain extract in combatting 
Staphylococcus  aureu$ infections in animals is due in great measure to the pre- 
TABLE IX 
Effect of Beef Brain Extract on the Toxin Production  by Staphylococcus aureus as Teated in Mice 
Type of filtrate 
Toxin filtrate of Staphylococcus 
aureus, control 
Toxin filtrate of Staphylococcus 
aureus, control plus extract... 
Toxin filtrate of Staphylococcm 
aureus, experimental. 
Average hemo- 
Mortality  globin 4th day 
of infection 
per cent  pc, cent 
100  23.4 
60  54.0 
10  91.2 
Average R.B.C. 
4th da~ of 
infectson 
2,136,000 
4,448,000 
9,625,000 
Necrosis 
10,  severe 
5,  moderate 
5,  slight 
2,  slight 
8,  none 
Ten mice in each series, weight of animals 20 gin. 
TABLE X 
Acute Toxicity of Beef Tissue Extracts in Mice over a 10 Day Period 
Type of extract 
Brain... 
Spleen. 
Heart.. 
Kidney... 
No, 
mice* 
12 
12 
10 
10 
Mortality at different dosages~ 
per  per  per 
con|  cent l Cen4 
0  0  0 
0  0  0 
20  40  80 
mg.  mg.,  mg. 
0  0  50 
0  0  50 
Average weight gain or loss 
& 
per 
cent 
0 
0 
140 
mg. 
50 
5O 
t 
per 
cent 
0 
0 
2OO 
mg. 
5O 
0 
per  ¢,¢~t  gin.  gin.  gin. 
100 +1.3+1.15 +1.6 +0.8 
100-0.8-0.2  +0.9-1.1 
20  40  8O 
mg.  mg.  mg. 
--0.1 -{-0.15 --1.2 --I.0 
--0.9 --1.7  --1.9 --0.9 
gm. 
140 
nag. 
gm.  Am. 
+1.25  -- 
--1.6 
200 
mg, 
--3.2 
--6.3 
* Average weight, 20 gin. 
Daily injections, subcutaneously. 
vention of toxin formation and only slightly to action on the formed toxin. 
Experimental study of the r61e of the tissue extracts in the general immunologic 
picture is in progress. 
Toxicity of Extracts 
Since previous experiments indicated that extracts of brain and spleen were 
less  toxic than those of heart and kidney, slightly higher dosage levels of the 260  EFFECTS 0~ TISSUE.EXTRACTS  ON  STAPHYLOCOCCUS  AUREUS 
former were used in acute toxicity tests.  The results demonstrate the greater 
toxicity of the heart and kidney extract (Table X).  Doses smaller than 500 
mg. of brain and spleen extract, a dosage approximately equivalent to2 to 2.5 
per cent of the body weight, did not kill the animal.  Injections of the spleen 
extract were accompanied by evidence of toxicity in the form of weight loss. 
Heart and kidney extracts, in addition to producing marked weight loss, re- 
suited in mortality with dosages as low as the 80 mg. level, an amount approxi- 
mately only 0.3 per cent of the body weight. 
The tests for chronic toxicity (Table XI), likewise showed brain and spleen 
extracts to be the safer materials.  The low mortality in animals receiving brain 
TABLE XI 
Chron~ ToUchy ~B~fTissueE~r~in Miceovera60-D~  Pe~od 
Type of extract  No. Mice*  Extract dosages Average.weightgam  Experlmentalbefore  deathinterval  Mortality 
Brain 
Spleen 
Heart 
Kidney 
10 
10 
10 
10 
~g. 
50 
100 
50 
100 
20 
40 
20 
40 
gm. 
5.5 
7.1 
5.9 
4.3 
day 
50th-58th 
58th 
27th-39th 
25th-55th 
35th-42nd 
26th-41st 
27th-40th 
8th-3Oth 
6 
6 
* Average weight, 20 gin. 
Daily injections, subcutaneously 
extract occurred only within the last few days of the 60 day experiment.  Mor- 
tality from the use of spleen and heart extracts was greater than with brain, 
and occurrred in the third quarter of the experimental interval.  Mortality with 
the spleen extract was somewhat lower than that for the heart extract even 
though it was given at a higher dosage level.  The kidney extract produced 100 
per cent mortality with both dosages within 40 days after beginning injections. 
SUMMARY 
1.  The ability of alcoholic-precipitated extracts of beef tissue--brain, spleen, 
heart, and kidney--to stimulate the growth of Staphylococcus  aureus,  in  vitro, 
and to convert the yellow S form to a white R variant with altered biochemical 
characteristics  conforming  to  those  of  an  avirulent  organism,  has  been 
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2.  The avirulence of the white R variant has been established by tests in d~o 
on mice. 
3.  St~phylococc~,  aureu¢  infections induced subcutaneously, intraperitone- 
ally, and intravenously in mice responded favorably to brain extract following 
subcutaneous or oral administration.  The mortality was 2 per cent in 4~ ex- 
perhnental animals and 81 per cent in 448 control animals. 
4.  The extracts appeared equally efficient when used therapeutically (mor- 
tality  2  per  cent  of  162  experimental  animals  and  90  per  cent  in  the 
control series)  or prophylactically (mortality 2 per cent of 282  experimental 
animals and 76 per cent in 286 control mice).  Extracts of brain and spleen 
were more effective than those of either heart or kidney. 
5.  Studies concerning the mechanism of action of the tissue extracts indicate 
that they prevented the formation of toxin by Staphylococcus  aum~,~, and had 
but little effect on toxin actions. 
6.  Toxicity tests revealed that the brain and spleen extracts were relatively 
non-toxic, dosages equivalent to 2 per cent of the body weight being well toler- 
ated.  Kidney and heart extracts were much more toxic, producing mortality 
in dosages as low as 0.3 per cent of the body weight. 
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